InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AlloVir (ALVR) stock is taking off on Wednesday following an update from the U.S. Food and Drug Administration (FDA) on posoleucel.
The post Why Is AlloVir (ALVR) Stock Up 30% Today? appeared first on InvestorPlace.
More From InvestorPlace